Latest Breaking News On - Fourth quarter bringing - Page 1 : comparemela.com

/PRNewswire/ Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue.

United statesLuis sanayJeffreym daynoDrug administrationParagon biosciencesZynerba pharmaceuticalsExchange commissionPrnewswire harmony biosciences holdings incShare repurchase programPreliminary net revenueFourth quarterFull yearRepresenting growthProduct revenue projected betweenCommon stock repurchaseFourth quarter bringing